Glycosylation of MUC1 influences the binding of a therapeutic antibody by altering the conformational equilibrium of the antigen

Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy

(2016) Christina Pfirschke et al.   IMMUNITY

Targeting neoantigens for cancer immunotherapy: Table 1.

(2016) Yong-Chen Lu et al.   INTERNATIONAL IMMUNOLOGY

Effects of the multiple O-glycosylation states on antibody recognition of the immunodominant motif in MUC1 extracellular tandem repeats

(2016) Shobith Rangappa et al.   MedChemComm

Deciphering the Non-Equivalence of Serine and ThreonineO-Glycosylation Points: Implications for Molecular Recognition of the Tn Antigen by an anti-MUC1 Antibody

(2015) Nuria Martínez-Sáez et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

MUC1 (CD227): a multi-tasked molecule

(2015) Vasso Apostolopoulos et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Linear synthesis and immunological properties of a fully synthetic vaccine candidate containing a sialylated MUC1 glycopeptide

(2015) Pamela Thompson et al.   CHEMICAL COMMUNICATIONS

Cancer Neoantigens and Applications for Immunotherapy

(2015) A. Desrichard et al.   CLINICAL CANCER RESEARCH

Antibody-based immunotherapy of solid cancers: progress and possibilities

(2015) Christopher F Nicodemus   Immunotherapy

Enhanced immunogenicity of multivalent MUC1 glycopeptide antitumour vaccines based on hyperbranched polymers

(2015) M. Glaffig et al.   ORGANIC & BIOMOLECULAR CHEMISTRY

Neoantigens in cancer immunotherapy

(2015) T. N. Schumacher et al.   SCIENCE

The effect of glycosylation on the antibody recognition of a MUC2 mucin epitope

(2014) Katalin Uray et al.   BIOPOLYMERS

Immune and Anticancer Responses Elicited by Fully Synthetic Aberrantly Glycosylated MUC1 Tripartite Vaccines Modified by a TLR2 or TLR9 Agonist

(2014) Abu-Baker M. Abdel-Aal et al.   CHEMBIOCHEM

A straightforward protocol for the preparation of high performance microarray displaying synthetic MUC1 glycopeptides

(2013) Takahiko Matsushita et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Exploring the cross-reactivity of S25-2: complex with a 5,6-dehydro-Kdo disaccharide

(2012) Cory L. Brooks et al.   Acta Crystallographica Section F-Structural Biology and Crystallization Communications

MUC1 immunotherapy is here to stay

(2012) Takashi Kimura et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Randomized Phase II Trial of Letrozole plus Anti-MUC1 Antibody AS1402 in Hormone Receptor-Positive Locally Advanced or Metastatic Breast Cancer

(2011) N. K. Ibrahim et al.   CLINICAL CANCER RESEARCH

LigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug Discovery

(2011) Roman A. Laskowski et al.   Journal of Chemical Information and Modeling

Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine

(2011) V. Lakshminarayanan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

PHENIX: a comprehensive Python-based system for macromolecular structure solution

(2010) Paul D. Adams et al.   ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

(2010) F. Stephen Hodi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Antibody recognition of a unique tumor-specific glycopeptide antigen

(2010) C. L. Brooks et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice

(2009) Sean O. Ryan et al.   BIOLOGICAL CHEMISTRY

IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis

(2008) X. Brochet et al.   NUCLEIC ACIDS RESEARCH

IMGT(R), the international ImMunoGeneTics information system(R)

(2008) M.-P. Lefranc et al.   NUCLEIC ACIDS RESEARCH